REVISIONES, METAANÁLISIS Y ENSAYOS
Efecto hepatoprotector de la especie medicinal Rosmarinus officinalis (Romero)
Hepatoprotective effect of the medicinal plant Rosmarinus officinalis (Rosemary)
Volumen 5, Número 1
Enero-Junio 2021
Páginas 45-50
Alicia Georgina Siordia-Reyes (1), María Adelina Jiménez-Arellanes (2).
Afiliaciones:
1. Anatomía Patológica, UMAE Hospital de Pediatría “Dr. Silvestre Frenk Freund”, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social. Ciudad de México, México.
2. Unidad de Investigación Médica en Farmacología, UMAE Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social. Ciudad de México, México.
Correspondencia:
María Adelina Jiménez-Arellanes: adelinajim08@prodigy.net.mx
2021 © Siordia-Reyes AG, Jiménez-Arellanes MA. Efecto hepatoprotector de la especie medicinal Rosmarinus officinalis (Romero).
Esta obra se distribuye bajo una Licencia Creative Commons Reconocimiento-NoComercial 4.0 Internacional (CC BY-NC).
Conflictos de Interés: Los autores declaran que no tienen conflictos de interés.
Fuentes de Financiamiento: Ninguna.
Sugerencia de cita:
Siordia-Reyes AG, Jiménez-Arellanes MA. Efecto hepatoprotector de la especie medicinal Rosmarinus officinalis (Romero). Rev Cadena Cereb. 2021; 5(1): 45-50.
Recibido: 15 de julio de 2020.
Aceptado: 9 de septiembre de 2020.
Publicado: 9 de septiembre de 2020.
RESUMEN
Rosmarinus officinalis (romero) es una especie que se distribuye en territorio mexicano. Es empleada como condimento, ornamental y de amplio uso medicinal. En la medicina tradicional es usada para infecciones vaginales, problemas cardiacos, cicatrización de heridas, en el manejo de la diabetes mellitus tipo 2 y obesidad, como antiaterogénico, neuro y hepatoprotector.
Esta especie biosintetiza compuestos como ácido betulínico, ácido rosmarínico, ácido carnósico, carnosol, rosmanol, ácido micromérico, ácido cafeico, ácido oleanólico y ácido ursólico, borneol, verbenona, α y β-amirina, fitol y diversos compuestos fenólicos como flavonoides (luteolina, genkwanina, campferol y otros), a los que se atribuye su actividad antioxidante, antiinflamatoria, anticancerígena y antimicrobiana. A pesar de ser muy empleada en la medicina tradicional con importante efecto antioxidante y antiinflamatorio, son pocos los trabajos que exploran su efecto hepatoprotector (HPP). El objetivo de esta revisión fue recopilar la evidencia científica disponible sobre el efecto protector de extractos de R. officinalis frente al daño inducido con diversos agentes hepatotóxicos en modelos in vivo.
A la fecha, solo nueve artículos describen el efecto HPP de extractos polares contra el daño inducido con tetracloruro de carbono, tioacetamida, creosato, ciclofosfamida y acetato de plomo.
Palabras Clave:
Hepatoprotección, Rosmarinus officinalis, Extractos polares, Efecto hepatoprotector.
ABSTRACT
Rosmarinus officinalis (rosemary) is distributed throughout the Mexican territory. It is used as a condiment, ornamental and for a wide medicinal use. In traditional medicine, it is used to treat digestive tract and respiratory tract ailments, vaginal infections, for heart problems, wound healing, against diabetes mellitus TII, obesity, antiatherogenic and neuroprotective, and to promote liver function and the production of bile.
This species biosynthesizes several compounds such as betulinic acid, rosmarinic acid, carnosic acid, carnosol, rosmanol, micomeric acid, caffeic acid, oleanolic acid and ursolic acid, borneol, verbenone, α and β-amirin, phytol and various phenolic compounds such as flavonoids (luteolin, genkwanina, campferol and others), which show antioxidant, anti-inflammatory, anticancer and antimicrobial activities. Despite being widely used in traditional medicine with an important antioxidant and anti-inflammatory effect, few studies have explored its hepatoprotective (HPP) effect. The objective of this review was to collect the existing information on the HPP effect of R. officinalis extracts against damage induced with some hepatotoxic agents.
Nowadays, only nine papers describe the HPP effect of R. officinalis (polar extracts) against damage induced with carbon tetrachloride, thioacetamide, creosate, cyclophosphamide, azatriophine and lead acetate.
Keywords:
Hepatoprotection, Rosmarinus officinalis, Polar extracts, Hepatoprotective activity.
REFERENCIAS
1. Begum A, Sandhya S, Ali SS, Vinod KR, Reddy S, Banji D. An in-depth review on the medicinal flora Rosmarinus officinalis (Lamiaceae). Acta Sci Pol Technol Aliment. 2013; 12(1): 61-73. Disponible en: https://www.food.actapol.net/volume12/issue1/abstract-6.html
2. Borrás-Linares I, Stojanović Z, Quirantes-Piné R, Arráez-Román D, Švarc-Gajić J, Fernández-Gutiérrez A, et al. Rosmarinus officinalis leaves as a natural source of bioactive compounds. Int J Mol Sci. 2014; 15(11): 20585-20606. DOI: 10.3390/ijms151120585
3. Soria C, Miranda ML, Flores ME, Pérez MI, Rodríguez RY, López AL, et al. Protective effect of Rosmarinus officinalis L. on the expression of the glutamate transporter (GLT-1) and neuronal damage in the frontal cortex of CCl4-induced hepatic damage. J Med Plants Res. 2012; 6(49): 5886-5894. Disponible en: https://academicjournals.org/article/article1380719518_Fregozo%20et%20al.pdf
4. Alfonso MS, de O Silva AM, Carvalho EB, Rivelli DP, Barros SB, Rogero MM, et al. Phenolic compounds from Rosemary (Rosmarinus officinalis L.) attenuate oxidative stress and reduce blood cholesterol concentrations in diet-induced hypercholesterolemic rats. Nutr Metab (Lond). 2013; 10(1): 19. DOI: 10.1186/1743-7075-10-19
5. Harach T, Aprikian O, Monnard I, Moulin J, Membrez M, Béolor J-C, et al. Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet. Planta Med. 2010; 76(6): 566-71. DOI: 10.1055/s-0029-1240612
6. Romo-Vaquero M, García-Villalba R, Larrosa M, Yáñez-Gascón MJ, Fromentin E, Flanagan J, et al. Bioavailability of the major bioactive ditepenoids in a rosemary extract: metabolic profile in the intestine, liver, plasma, and brain of Zucker rats. Mol Nutr Food Res. 2013; 57(10): 1834-46. DOI: 10.1002/mnfr.201300052
7. Romo M, Yáñez-Gascón M-J, García R, Larrosa M, Fromentin E, et al. Inhibition of Gastric Lipase as a Mechanism for Body Weight and Plasma Lipids Reduction in Zucker Rats Fed a Rosemary Extract Rich in Carnosic Acid. PLoS ONE. 2012; 7(6): e39773. DOI: 10.1371/journal.pone.0039773
8. Mahboobeh GR, Bahareb A, Soghra M, Seyed JM-Z, Hossein H. Anti-inflammatory effects of ethanolic extract of Rosmarinus officinalis L. and rosmarinic acid in rat model of neuropathic pain. Biomed Pharmacother. 2017; 86: 441-49. DOI: 10.1016/j.biopha.2016.12.049
9. Moore J, Yousef M, Tsiani E. Anticancer Effects of Rosemary (Rosmarinus offcinalis L.) Extract and Rosemary Extract Polyphenols. Nutrients. 2016; 8(11): 731. DOI: 10.3390/nu8110731
10. Silva S, Alves N, Silva P, Vieira T, Maciel P, Castellano LR, et al. Antibacterial activity of Rosmarinus officinalis, Zingiber officinale, Citrus aurantium bergamia, and Copaifera officinalis alone and in combination with calcium hydroxide against Enterococcus faecalis. Biomed Res Int. 2019; 2019: 8129439. DOI: 10.1155/2019/8129439
11. González-Vallinas M, Reglero G, Ramírez A. Rosemary (Rosmarinus officinalis L.) Extract as a Potential Complementary Agent in Anticancer Therapy. Nutr Cancer. 2015; 67(8): 1221-9. DOI: 10.1080/01635581.2015.1082110
12. Hanson JR. Rosemary, the beneficial chemistry of garden herb. Sci Prog. 2016; 99(1): 83-91. DOI: 10.3184/003685016X14495646283298
13. Mohamed WAM, Abd-Elhakim YM, Farouk SM. Protective effects of ethanolic extract of rosemary against lead-induced hepato-renal damage in rabbits. Exp Toxicol Pathol. 2016; 68(8): 451-61. DOI: 10.1016/j.etp.2016.07.003
14. Ngo SNT, Williams DB, Head RJ. Rosemary and cancer prevention: preclinical perspectives. Crit Rev Food Sci Nutr. 2011; 51(10): 946-54. DOI: 10.1080/10408398.2010.490883
15. Peng C-H, Su J-D, Chyau C-C, Sung T-Y, Ho S-S, Peng C-C, et al. Supercritical fluid extracts of Rosemary leaves exhibit potent anti-inflammation and anti-tumor effects. Biosci Biotechnol Biochem. 2007; 71(9): 2223-32. DOI: 10.1271/bbb.70199
16. Rocha J, Eduardo-Figueira M, Barateiro A, Fernandes A, Brites D, Bronze R, et al. Anti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation. Basic Clin Pharmacol Toxicol. 2015; 116(5): 398-413. DOI: 10.1111/bcpt.12335
17. Takaki I, Bersani-Amado LE, Vendruscolo A, Sartoretto SM, Diniz SP, Bersani-Amado CA, et al. Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Med Food. 2008; 11(4): 741-6. DOI: 10.1089/jmf.2007.0524
18. Lorenzo-Leal AC, Palou E, López-Malo A, Bach H. Antimicrobial, Cytotoxic and Anti-Inflammatory Activities of Pimenta dioica and Rosmarinus officinalis Essential Oils. Biomed Res Int. 2019; 2019: 1639726. DOI: 10.1155/2019/1639726
19. Jiménez-Arellanes MA. Silimarina como potencial agente hepatoprotector. Rev Cadena Cereb. 2019; 3(2): 60-70. DOI: 10.5281/zenodo.3903937
20. Ramadan KS, Khalil OA, Danial EN, Alnahdi HS, Ayas NO. Hypoglycemic and hepatoprotective activity of Rosmarinus officinalis extract in diabetic rats. J Physiol Biochem. 2013; 69(4): 779-83. DOI: 10.1007/s13105-013-0253-8
21. El-Demerdash FM, Abbady EA, Baghdadi HH. Oxidative stress modulation by Rosmarinus officinalis in creosote-induce hepatotoxicity. Environ Toxicol. 2014; 31(1):85-92. DOI: 10.1002/tox.22024
22. Galisteo M, Suárez A, Montilla MP, Fernandez MI, Gil A, Navarro MC. Protective effects of Rosmarinus tomentosus ethanol extract on thioacetamide-induced liver cirrhosis in rats. Phytomedicine. 2006; 13(1-2):101-108. DOI: 10.1016/j.phymed.2004.06.024
23. Amin A, Hamza AA. Hepatoprotective effects of Hibiscus, Rosmarinus and Salvia on azathioprine-inducted toxicity in rats. Life Sci. 2005; 77(3): 266-78. DOI: 10.1016/j.lfs.2004.09.048
24. Sotelo-Félix JI, Martinez-Fong D, Muriel P. Protective effect of carnosol on CCl4-induced acute liver damage in rats. Eur J Gastroenterol Hepatol. 2002; 14(9): 1001-1006. Disponible en: https://journals.lww.com/eurojgh/Abstract/2002/09000/Protective_effect_of_carnosol_on_CCl4_induced.11.aspx
25. Sotelo-Félix JI, Martinez-Fong D, Muriel P, Santillán RL, Castillo D, Yahuaca P. Evaluation of the effectiveness of Rosmarinus officinalis (Lamiaceae) in the alleviation of carbon tetrachloride-induced acute hepatotoxicity in the rat. J Ethnopharmacol. 2002; 81(2): 145-154. DOI: 10.1016/s0378-8741(02)00090-9
26. Gutiérrez R, Alvarado JL, Presno M, Pérez-Veyna O, Serrano CJ, Yahuaca P. Oxidative stress modulation by Rosmarinus officinalis in CCl4-induced liver cirrhosis. Phytother Res. 2010; 24(4): 595-601. DOI: 10.1002/ptr.2997
27. El-Naggar SA, Abdel-Farid IB, Germoush MO, Elgebaly HA, Alm-Eldeen AA. Efficacy of Rosmarinus officinalis leaves extract against cyclophosphamide-induced hepatotoxicity. Pharm Biol. 2016; 54(10): 2007-16. DOI: 10.3109/13880209.2015.1137954
28. Rašković A, Malinović I, Pavlović N, Cebović T, Vukmirović S, Mikov M. Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC Complem Altern Med. 2014; 14:225 (1-9). DOI: 10.1186/1472-6882-14-225